Experience contributing to a preclinical cell therapy program (in vivo or ex vivo); Expertise in flow cytometry using both antibody panels and fluorescent reporters; Experience developing novel methods for gene editing off-target analytics using both long and short-read sequencing; Mechanistic understanding of gene editing tools, including nucleases, base editors, transposons, retrotransposons, and recombinases; Ability to reason about proteins as molecular machines; Experience integrating AI protein design tools with high-throughput wet lab screening methodologies; Fluency in NGS instrumentation, basic bioinformatics tools, and traceable data pipelines. Experience with gene editing, NGS assay development, protein engineering and cell therapy; Experience with high-throughput methods of cloning and producing DNA constructs for cellular screening; Experience with mammalian cell culture, transfection, and cell-line generation; Knowledge of emerging technologies in gene editing and on/off-target analytics that enable regulatory approval; Expertise with DNA/RNA extraction, PCR, ddPCR, NGS library preparation and QC.